Predictions
AIB Group Plc
Start price
Target price
Perf. (%)
€2.41
27.12.21
27.12.21
-
27.12.22
27.12.22
-7.64%
07.01.22
07.01.22
Probably not worthwhile Investment
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€143.65
27.12.21
27.12.21
-
27.12.22
27.12.22
-9.78%
09.01.22
09.01.22
Risky Investment
Biogen Inc.
Start price
Target price
Perf. (%)
€208.25
27.12.21
27.12.21
€215.00
27.12.22
27.12.22
23.82%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.99
27.12.21
27.12.21
€42.00
27.12.22
27.12.22
-5.05%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Pluristem Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.41
27.12.21
27.12.21
€2.50
27.12.22
27.12.22
-31.19%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.97
27.12.21
27.12.21
€6.00
27.12.22
27.12.22
-83.85%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
New Oriental Education & Technology Group
Start price
Target price
Perf. (%)
€1.75
27.12.21
27.12.21
-
27.12.25
27.12.25
118.29%
23.01.23
23.01.23
Could be worthwhile Investment >10% per year
Gaotu Techedu Inc. ADR
Start price
Target price
Perf. (%)
€1.66
27.12.21
27.12.21
-
27.12.25
27.12.25
123.49%
22.12.22
22.12.22
Could be worthwhile Investment >10% per year
Bridgebio Pharma Inc.
Start price
Target price
Perf. (%)
€12.20
27.12.21
27.12.21
€15.00
27.12.22
27.12.22
5.74%
08.01.22
08.01.22
Could be worthwhile Investment >10% per year
Good culture
Capable Management
No uniques
Münchener Rückversicherungs-Gesellschaft AG
Start price
Target price
Perf. (%)
€257.65
27.12.21
27.12.21
-
27.12.22
27.12.22
18.26%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Hapag Lloyd AG
Start price
Target price
Perf. (%)
€259.40
27.12.21
27.12.21
-
27.12.22
27.12.22
-25.48%
28.12.22
28.12.22
Good culture
Some uniques
Could be worthwhile Investment >10% per year
Capable Management
Rational AG
Start price
Target price
Perf. (%)
€899.00
27.12.21
27.12.21
-
27.12.22
27.12.22
-38.15%
28.12.22
28.12.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
Odonate Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
27.12.21
27.12.21
-
27.12.22
27.12.22
-24.02%
08.01.22
08.01.22
Could be worthwhile Investment >10% per year
Innovative
Good culture
Few uniques
Biora Therapeutics Inc.
Start price
Target price
Perf. (%)
€50.50
27.12.21
27.12.21
€100.00
27.12.22
27.12.22
-14.36%
10.01.22
10.01.22
Could be very worthwhile Investment >20% year
51 Talk Online Education Group ADR
Start price
Target price
Perf. (%)
€4.08
27.12.21
27.12.21
-
18.01.25
18.01.25
93.63%
27.01.23
27.01.23
Could be worthwhile Investment >10% per year
Neonode Inc.
Start price
Target price
Perf. (%)
€8.40
26.12.21
26.12.21
€6.00
-
28.05.23
28.05.23
Could be worthwhile Investment >10% per year
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€7.34
26.12.21
26.12.21
€10.00
26.12.22
26.12.22
10.35%
25.09.22
25.09.22
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
IBU tec advanced materials AG
Start price
Target price
Perf. (%)
€48.90
26.12.21
26.12.21
€55.00
26.12.22
26.12.22
-8.79%
08.01.22
08.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
positive Cash Flow expected
Metaverse Capital Corp.
Start price
Target price
Perf. (%)
€0.003
26.12.21
26.12.21
-
-
30.05.23
30.05.23
Could be worthwhile Investment >10% per year
PVA TePla AG
Start price
Target price
Perf. (%)
€41.85
26.12.21
26.12.21
€48.00
26.12.22
26.12.22
-6.93%
08.01.22
08.01.22
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Normal challenges to pay loans and raise capital